Yair Lotan

Urology

1500 S Main St
Fort Worth, TX 76104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 587 publications

Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan.

Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan.

Journal: Future oncology (London, England)

Published: July 27, 2026

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

Journal: Nature reviews. Urology

Published: July 22, 2026

Unveiling the Paradoxical Tumor-Suppressive Role of CCL2/CCR2 in Bladder Cancer: A Novel Immunotherapeutic Strategy.

Unveiling the Paradoxical Tumor-Suppressive Role of CCL2/CCR2 in Bladder Cancer: A Novel Immunotherapeutic Strategy.

Journal: Cancers

Published: June 22, 2026

Development and validation of a computational histology artificial intelligence-powered prognostic biomarker in muscle-invasive bladder cancer.

Development and validation of a computational histology artificial intelligence-powered prognostic biomarker in muscle-invasive bladder cancer.

Journal: Urologic oncology

Published: May 18, 2026

Letter: Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Letter: Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Journal: The Journal of urology

Published: May 01, 2026

'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

Journal: BJU international

Published: April 28, 2026

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 13, 2026

Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.

Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.

Journal: Cancer letters

Published: April 09, 2026

Circulating Tumor DNA as a Novel Indicator of Teratoma in Nonseminomatous Germ Cell Tumor.

Circulating Tumor DNA as a Novel Indicator of Teratoma in Nonseminomatous Germ Cell Tumor.

Journal: Clinical genitourinary cancer

Published: March 22, 2026

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Journal: Nature reviews. Urology

Published: March 11, 2026

Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study.

Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study.

Journal: Journal of translational medicine

Published: March 06, 2026

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Journal: Journal of the National Cancer Institute

Published: March 05, 2026

Showing 1-12 of 587

Last Updated: 09/26/2026